New pill tested for Tough-to-Treat blood cancers
NCT ID NCT04842877
Summary
This study is testing an oral medication called valemetostat for people with B-cell lymphoma that has come back or stopped responding to standard treatments. About 141 participants will take the pill daily to see if it shrinks their tumors and is safe. The goal is to control the disease in patients who have few other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, B-CELL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
A.Z. Sint Jan AV
Bruges, 8000, Belgium
-
CH Tourelle Peltzer
Verviers, 4800, Belgium
-
CH d'Avignon
Avignon, 84000, France
-
CH de la Côte Basque
Bayonne, 64109, France
-
CHU Hôtel Dieu
Nantes, 44093, France
-
CHU Mont-Godinne
Yvoir, Belgium
-
CHU Pontchaillou
Rennes, 35003, France
-
CHU d'Estaing
Clermont-Ferrand, 63000, France
-
CHU de Dijon
Dijon, 21034, France
-
CHU de Montpellier
Montpellier, 34295, France
-
Ch Metropole Savoie - Site Chambery
Chambéry, 73000, France
-
Ch de Bretagne Atlantique -
Vannes, 56017, France
-
Chd de Vendee
La Roche-sur-Yon, 85925, France
-
Clinique Victor Hugo
Le Mans, 72000, France
-
Emmanuel Bachy
Pierre-Bénite, 69495, France
-
François Lemonnier
Créteil, 94010, France
-
Gh Region Mulhouse Et Sud Alsace
Mulhouse, 68070, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Paoli Calmette
Marseille, 13273, France
-
Institut d'Hématologie de Basse Normandie
Caen, 14076, France
-
Service des Maladies du Sang - CHRU de Lille
Lille, 59037, France
-
University Hospital Gent
Ghent, 9000, Belgium
Conditions
Explore the condition pages connected to this study.